These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 2157906

  • 1. [Radiotherapy combined with cis-diammine-dichloro platinum (II) plus vindesine in the treatment of non-small cell lung cancer: a comparison with treatment by radiation alone].
    Koga K, Minoda S, Murai N, Nishikawa K.
    Gan No Rinsho; 1990 Apr; 36(5):593-7. PubMed ID: 2157906
    [Abstract] [Full Text] [Related]

  • 2. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
    Ajlouni M, Chapman R, Kim JH.
    Cancer J Sci Am; 1996 Apr; 2(6):314-20. PubMed ID: 9166551
    [Abstract] [Full Text] [Related]

  • 3. [Concurrent high-dose thoracic irradiation plus daily low-dose cisplatin and vindesine in locally advanced unresectable stage III non-small cell lung cancer].
    Nakano K, Kumagai K, Ishida H, Kohjima N, Hiramoto T, Hada Y.
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):57-61. PubMed ID: 8546470
    [Abstract] [Full Text] [Related]

  • 4. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
    Stathopoulos GP, Dafni UG, Malamos NA, Rigatos S, Kouvatseas G, Moschopoulos N.
    Anticancer Res; 1999 Jan; 19(4C):3543-8. PubMed ID: 10629650
    [Abstract] [Full Text] [Related]

  • 5. Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer.
    Wolf M, Hans K, Becker H, Hässler R, von Bültzingslöwen F, Goerg R, Klaasen HA, Dannhäuser J, Holle R, Pfab R.
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):42-7. PubMed ID: 8209276
    [Abstract] [Full Text] [Related]

  • 6. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T, Pujol JL, Douillard JY, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, Besson F.
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [Abstract] [Full Text] [Related]

  • 7. [A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].
    Furuse K, Fukuoka M, Asamoto H, Niitani H, Kimura I, Sakuma A, Yamaguchi Y.
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1019-26. PubMed ID: 1320846
    [Abstract] [Full Text] [Related]

  • 8. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
    Chen GY, Jiang GL, Qian H, Wang LJ, Yang HJ, Fu XL, Wu KL, Zang Z, Zhao S.
    Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
    [Abstract] [Full Text] [Related]

  • 9. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P.
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F, Sica G, De Filippis S, Rosselli M, Saggio G, Guerriero G, Pompili P, Rea S.
    Anticancer Res; 2000 Feb; 20(3B):1985-90. PubMed ID: 10928138
    [Abstract] [Full Text] [Related]

  • 11. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y, Ueoka H, Kiura K, Kamei H, Tabata M, Sakae K, Hiraki Y, Kawahara S, Eguchi K, Hiraki S, Harada M.
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [Abstract] [Full Text] [Related]

  • 12. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ, Movsas B, Hudes R, Schol J, Keenan E, Kilpatrick D, Yeung C, Curran W.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [Abstract] [Full Text] [Related]

  • 13. Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA/B non-small cell carcinoma of the lung.
    Antonia SJ, Wagner H, Williams C, Alberts M, Hubbell D, Robinson L, Hilstro J, Ruckdeschel JC.
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):34-7. PubMed ID: 7644926
    [Abstract] [Full Text] [Related]

  • 14. A phase II study of hyperfractionated accelerated radiotherapy (HART) after induction cisplatin (CDDP) and vinorelbine (VNR) for stage III non-small-cell lung cancer (NSCLC).
    Ishikura S, Ohe Y, Nihei K, Kubota K, Kakinuma R, Ohmatsu H, Goto K, Niho S, Nishiwaki Y, Ogino T.
    Int J Radiat Oncol Biol Phys; 2005 Mar 15; 61(4):1117-22. PubMed ID: 15752891
    [Abstract] [Full Text] [Related]

  • 15. [UFT plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer--its application to outpatient practice].
    Yano T, Koga T, Nomiyama H, Hidaka H.
    Gan To Kagaku Ryoho; 2003 Jul 15; 30(7):959-62. PubMed ID: 12894710
    [Abstract] [Full Text] [Related]

  • 16. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
    Belani CP, Wang W, Johnson DH, Wagner H, Schiller J, Veeder M, Mehta M, Eastern Cooperative Oncology Group.
    J Clin Oncol; 2005 Jun 01; 23(16):3760-7. PubMed ID: 15837967
    [Abstract] [Full Text] [Related]

  • 17. [Combination chemotherapy including cisplatinum, vindesine and mitomycin C for non-small cell lung cancer].
    Hayashi Y, Kato M, Matsuura T, Yamada Y, Adachi S, Ito G, Yamamoto K, Takeuchi T.
    Gan To Kagaku Ryoho; 1990 Aug 01; 17(8 Pt 1):1455-60. PubMed ID: 2167632
    [Abstract] [Full Text] [Related]

  • 18. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
    Komaki R, Lee JS, Milas L, Lee HK, Fossella FV, Herbst RS, Allen PK, Liao Z, Stevens CW, Lu C, Zinner RG, Papadimitrakopoulou VA, Kies MS, Blumenschein GR, Pisters KM, Glisson BS, Kurie J, Kaplan B, Garza VP, Mooring D, Tucker SL, Cox JD.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1369-77. PubMed ID: 15050312
    [Abstract] [Full Text] [Related]

  • 19. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct 01; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 20. [Current results of chemotherapy in non-small cell lung cancer].
    Fukuoka M, Negoro S, Takada M, Matsui K, Takifuji N, Masuda N, Kawahara M, Furuse K.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb 01; 28(2):203-9. PubMed ID: 2162439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.